NEW YORK (
CHANGE IN RATINGS
downgraded at Leerink from Outperform to Market Perform. Valuation call, as potential risks lay ahead.
upgraded at Wells from Market Perform to Outperform. Estimates also raised, to reflect the company's comp sales momentum.
reinstated at BofA/Merrill. BHI coverage reinstated with a Buy rating and $61 price target. HBI has above average exposure to higher growth, early cycle product service lines.
reinstated at BofA/Merrill. CAM coverage reinstated with a Buy rating and $56 price target. Upside from integration of NATCO acquisition, Bank of America/Merrill Lynch said.
initiated at BofA/Merrill. CLB coverage initiated with a Buy rating and $136 price target. Buy based on continuation of share buybacks, valuation, and earnings acceleration.
rated new Neutral at UBS. Coverage of CTXS was started with a Neutral rating. $47 price target. Stock is already pricing in increased IT spending.
upgraded at JP Morgan from Neutral to Overweight. $65 price target. Seeing signs of a recovery in multiple areas of equipment.
estimates, target increased at UBS. Shares of DE now seen reaching $61. Estimates also raised, because of higher expected agriculture demand. Neutral rating.
initiated at BofA/Merrill. DRQ coverage initiated with a Buy rating and $68 price target. Recent capacity expansion is driving revenue growth.
( GENZ) reinstated at BofA/Merrill with an Underperform rating and $65 price target. Not many growth catalysts and poor valuation, Bank of America/Merrill Lynch said.
reinstated at BofA/Merrill with a Buy rating and $43 price target. Bank of America/Merrill Lynch noted growing international demand.
upgraded at Needham from Hold to Buy. $69 price target. Company is positioned well to grow in 2010.
price target cut at BofA/Merrill. ITRI price target lowered to $75 from $80. Estimates reduced through 2012. Maintain Buy rating.
National Oilwell Varco
reinstated at BofA/Merrill with a Buy rating and $51 price target. Bank of America/Merrill Lynch noted a recovery in the services business.
estimates, target increased at Goldman. Shares of NTAP now seen reaching $38. Estimates also boosted, as the company is seeing higher sales. Neutral rating.
upgraded at BofA/Merrill to Neutral from Underperform on valuation and higher steel prices. Price target jumped to $50, 2010 EPS estimate improved to $2.
downgraded at Sterne Agee from Buy to Neutral. $21 price target. Core Life Marketing segment remains under pressure.
rated new Buy at UBS. $54 price target. Company should benefit from reinvestment in datacenter projects.
downgraded at Keybanc from Buy to Hold. Valuation call.
estimates, target upped at Morgan Stanley. WSO estimates were increased through 2011. Company continues to grow its margins. Overweight rating and new $65 price target.
STOCK COMMENTS / EPS CHANGES
Advanced Auto Parts
forecasts reduced at Credit Suisse. AAP 2010 and 2011 EPS estimates lowered to $3.30 and $3.80, respectively. Maintain Outperform rating and $48 price target.
estimates, target boosted at Goldman. ADI estimates were increased through 2011. Company is realizing higher margin leverage. Buy rating and new $37 price target.
estimates raised at Goldman. AMAT estimates were increased through 2011. Company is seeing strong silicon orders. Buy rating and $17 price target.
numbers increased at UBS. CF estimates were raised through 2011. Company is seeing higher demand for Nitrogen and Phosphate. Neutral rating and new $104 price target.
estimates raised at UBS through 2010. Company guided toward higher production growth. Neutral rating and $29 price target.
numbers upped at Goldman Shares of DRI now seen reaching 2012. Estimates also boosted, to reflect better sales and margins. Neutral rating and new $44 price target.
estimates boosted at Goldman through 2011. Company is seeing higher production rates and lower costs. Buy rating and $96 price target.
target upped at UBS. Shares of EMC now seen reaching $21. Company likely to benefit from momentum at VMW. Buy rating.
( GENZ) price target raised at Credit Suisse. FTI price target jumped to $57 from $54 after solid 4Q09 results. 2010 and 2011 EPS estimates increased to $2.60 and $2.90, respectively. Maintain Neutral rating.
( GENZ) numbers upped at FBR. Shares of FTI now seen reaching $77. Estimates also boosted, as the company has tremendous order potential in 2010. Outperform rating.
( GENZ) price target boosted at BofA/Merrill to $54 from $47 based on switching from a multiple-based valuation to discounted cashflow, as investors view GENZ as a break up saleable company. Maintain Underperform rating.
( GENZ) estimates, target reduced at Goldman. Shares of GENZ now seen reaching $51. Estimates also cut, as the company is facing higher expenses. Sell rating.
price target increased at BofA/Merrill to $62 from $60 after solid 1Q10 results. Estimates raised through 2012.
numbers raised at Goldman. HPQ estimates were increased through 2011. Company is gaining share and has strong operating leverage. Buy rating and new $61 price target.
estimates cut at Morgan Stanley. LIFE estimates were lowered through 2012. Recent debt offering increases interest expense, but still makes strategic sense. Overweight rating and $57 price target.
Las Vegas Sands
estimates lowered at UBS. LVS estimates were cut through 2010. Weak Las Vegas results will continue to weigh on results. Buy rating and $20 price target.
estimates, target increased at UBS. Shares of NBR now seen reaching $25, according to UBS. Estimates also boosted, because of better U.S. pricing. Neutral rating.
numbers increased at Goldman. NFX estimates were raised through 2012. Company can deliver double-digit production and free cash flow growth. Buy rating and new $63 price target.
target, estimates boosted at Credit Suisse. NTAP price target raised to $29 from $27 on signs of networked storage recovery. 2010 and 2011 EPS estimates surged to $1.43 and $1.62, respectively. Neutral rating.
estimates, target increased at Goldman. Shares of NVDA now seen reaching $16. Estimates also boosted, to reflect the company's higher gross margin. Neutral rating.
estimates, target raised at Goldman. Shares of OMX now seen reaching $17.50. Estimates also upped, as the company is seeing better sales. Buy rating.
target, estimates boosted at BofA/Merrill. PCLN price target increased to $300 from $228 on higher estimates. Estimates raised through 2011. Maintain Buy rating.
numbers raised at Goldman. Shares of PCLN now seen reaching $265. Estimates also boosted, given better sales in Europe. Buy rating.
numbers increased at Morgan Stanley. Shares of PVH now seen reaching $51. Estimates also upped, as the company is seeing better demand across the board. Overweight rating.
estimates raised at Morgan Stanley through 2011. Company is seeing better production from it new wells in the Gulf Coast. Overweight rating and $65 price target.
This article was written by a staff member of TheStreet.com.